New Nerve-Zapping procedure tested for back pain relief
NCT ID NCT05660512
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 150 people who received the Intracept Procedure, which uses radiofrequency energy to ablate the basivertebral nerve in the spine. The goal is to see if this reduces disability from chronic low back pain. Participants fill out questionnaires about their pain and daily activities before and after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Radiofrequency ablation of the basivertebral nerve (Intracept Procedure)
- What this could lead to
- If successful, this could confirm that nerve ablation is a reliable option for reducing chronic low back pain and improving daily function.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less definitive. Pain relief varies, and the procedure carries risks like infection or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2020
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients at the single study site who are offered an Intracept Procedure are eligible and will be approached to participate in this study. Up to 150 participants who are planning to be treated with the Intracept Procedure will be consented and ultimately, 50 participants with 12 months of follow-up data will be followed.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All patients scheduled for intraosseous basivertebral nerve ablation with the Intracept Procedure * OR Participant had an Intracept Procedure for their low back pain and completed standard of care questionnaires at their procedure appointment. Exclusion Criteria: * Not scheduled for an intraosseous basivertebral nerve ablation with the Intracept Procedure * Intracept procedure for different location other than low back pain
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Low back pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah Farmington Health Center
Farmington, Utah, 84025, United States
-
University of Utah Orthopaedic Center
Salt Lake City, Utah, 84108, United States
-
University of Utah South Jordan Health Center
South Jordan, Utah, 84009, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pilates takes on standard physical therapy in battle against Work-Related back pain
- Radiofrequency device tested as Add-On for stubborn back pain
- Back muscles hold clues for treating recurrent low back pain
- Skip the GP? physiotherapy first for back pain put to the test
- Can yoga ease back pain when recovery looks unlikely?
- Can a second injection target the source of stubborn back pain?